BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Somatic Cell Gene Editing - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Somatic Cell Gene Editing
X-ORIGINAL-URL:https://scge.mcw.edu
X-WR-CALDESC:Events for Somatic Cell Gene Editing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240605T100000
DTEND;TZID=America/Chicago:20240605T143000
DTSTAMP:20260411T022006
CREATED:20240415T153357Z
LAST-MODIFIED:20240415T153357Z
UID:4206-1717581600-1717597800@scge.mcw.edu
SUMMARY:The State of CRISPR and Gene Editing
DESCRIPTION:In The State of CRISPR and Gene Editing virtual summit\, GEN proudly gathers a tantalizing line-up of luminaries from academia and industry to discuss the latest research developments\, innovations\, and advanced technologies that are expanding the CRISPR toolbox\, delivering new therapies to patients and safeguarding our food supply. The webinar is virtual and free to attend. SCGE Researcher David Liu will be giving the opening keynote.\n\nLearn more at https://webinars.liebertpub.com/e/the-state-of-crispr-and-gene-editing-2024
URL:https://scge.mcw.edu/events/the-state-of-crispr-and-gene-editing/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/04/Screenshot-2024-04-15-103326.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240611
DTEND;VALUE=DATE:20240614
DTSTAMP:20260411T022006
CREATED:20240125T172226Z
LAST-MODIFIED:20240125T172226Z
UID:3913-1718064000-1718323199@scge.mcw.edu
SUMMARY:Cell and Gene Therapy Products Symposium
DESCRIPTION:The Cell and Gene Therapy Products (CGTP) Symposium: Manufacturing\, Quality and Regulatory Considerations enables the exchange of scientific ideas and dialogue with regulators that form the basis of evolving regulatory practices in the development of these diverse and innovative products. \nRockville\, MD \nhttps://www.casss.org/cell-gene-therapy-products
URL:https://scge.mcw.edu/events/cell-and-gene-therapy-products-symposium/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/01/Screenshot-2024-01-25-112158.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240612
DTEND;VALUE=DATE:20240615
DTSTAMP:20260411T022006
CREATED:20240329T154054Z
LAST-MODIFIED:20240329T154054Z
UID:4170-1718150400-1718409599@scge.mcw.edu
SUMMARY:Next Generation Gene Therapy Vectors
DESCRIPTION:This event will focus on finding and optimizing novel vectors to increase specificity\, target new cell types\, expand packaging capacities\, and reduce toxicity risks to create safer\, cost-effective and efficacious gene therapies. \nLearn more at https://next-gen-genetherapy-vectors.com/
URL:https://scge.mcw.edu/events/next-generation-gene-therapy-vectors/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/03/gene-therapy-event-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240616
DTEND;VALUE=DATE:20240621
DTSTAMP:20260411T022006
CREATED:20240424T202320Z
LAST-MODIFIED:20240424T202320Z
UID:4216-1718496000-1718927999@scge.mcw.edu
SUMMARY:Genome Engineering: Research and Applications
DESCRIPTION:The conference seeks to present the latest research findings in these fields and support early-career investigators\, women\, and other historically-excluded groups in the field of genome editing. Through collaboration and networking at this meeting\, it can accelerate the translation of fundamental advances into viable genome editing technologies. The conference is being held in Rome\, Italy. \nSCGE researcher Shengdar Tsai is one of the conference organizers\, and SCGE researcher David Liu is the keynote speaker. \nLearn more at https://events.faseb.org/event/genome-engineering-research-applications/summary \n 
URL:https://scge.mcw.edu/events/genome-engineering-research-and-applications/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/04/Screenshot-2024-04-24-152220.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240626
DTEND;VALUE=DATE:20240629
DTSTAMP:20260411T022006
CREATED:20231220T180311Z
LAST-MODIFIED:20231220T180311Z
UID:3287-1719360000-1719619199@scge.mcw.edu
SUMMARY:RNA Therapeutics
DESCRIPTION:Learn more about RNA Therapeutics from concept to clinic from leaders across the field\, including SCGE PI’s Jennifer Doudna\, Kiran Musunuru\, and Sonia Vallabh. \nhttps://www.umassmed.edu/RNATx/
URL:https://scge.mcw.edu/events/rna-therapeutics/
ATTACH;FMTTYPE=image/jpeg:https://scge.mcw.edu/wp-content/uploads/2023/12/RNA-Therapeutics-24.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240708
DTEND;VALUE=DATE:20240711
DTSTAMP:20260411T022006
CREATED:20240125T172523Z
LAST-MODIFIED:20240125T172523Z
UID:3916-1720396800-1720655999@scge.mcw.edu
SUMMARY:The Global Cell & Gene Therapy Summit
DESCRIPTION:The International Summit on Cell and Gene Therapy serves as a platform to explore the fundamental concepts of these transformative therapies. The summit brings together experts from academia and industry to discuss a range of topics related to cell and gene therapy\, including ethical considerations\, social implications\, tools\, techniques\, marketing strategies\, and the commercialization of cell and gene therapy products. It also showcases the latest research progress in CGT and explores opportunities for further enhancements in availability and productivity of these therapies. \nBoston\, MA (Hybrid) \nhttps://cgtsummit.com/
URL:https://scge.mcw.edu/events/the-global-cell-gene-therapy-summit/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/01/Screenshot-2024-01-25-112452.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240709
DTEND;VALUE=DATE:20240712
DTSTAMP:20260411T022006
CREATED:20240612T154313Z
LAST-MODIFIED:20240612T154313Z
UID:4280-1720483200-1720742399@scge.mcw.edu
SUMMARY:In Vivo Cell Engineering & Gene Editing Summit
DESCRIPTION:Achieve Safe & Targeted In Vivo Delivery of Payloads with Clarity in Regulations & Appropriate Models to Advance the Next Frontier of In Vivo Editing from Research to Clinic. \nBoston\, MA
URL:https://scge.mcw.edu/events/in-vivo-cell-engineering-gene-editing-summit/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-104251.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240716
DTEND;VALUE=DATE:20240718
DTSTAMP:20260411T022006
CREATED:20240612T153359Z
LAST-MODIFIED:20240612T153359Z
UID:4274-1721088000-1721260799@scge.mcw.edu
SUMMARY:CMC Strategy Forum North America
DESCRIPTION:The CMC Strategy Forum has established an excellent reputation for being the premier scientific meeting that brings together regulatory\, industry\, and academic professionals to discuss key emerging CMC issues that affect biotechnology in an open and transparent workshop format. The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product. \n\nGaithersburg\, MD
URL:https://scge.mcw.edu/events/cmc-strategy-forum-north-america-july/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-103213.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240820
DTEND;VALUE=DATE:20240823
DTSTAMP:20260411T022006
CREATED:20240612T154617Z
LAST-MODIFIED:20240612T154617Z
UID:4283-1724112000-1724371199@scge.mcw.edu
SUMMARY:Next Generation Lipid-Based Nanoparticles Delivery Summit
DESCRIPTION:The 3rd Next Generation Lipid-Based Nanoparticles Delivery Summit is the only event dedicated entirely to lipid-based nanoparticle delivery\, where we bring together 120+ experts in LNP non-clinical\, delivery\, particle engineering\, and formulation from the likes of Teressa\, Sanofi\, MediciBio\, CureVac. Together\, we’re on a mission to revolutionize drug delivery\, conquering the intricate challenges of lipid-based nanoparticle delivery beyond RNAs and extending cargos to destinations beyond the liver. \nBoston\, MA \n 
URL:https://scge.mcw.edu/events/next-generation-lipid-based-nanoparticles-delivery-summit/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-104553.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240827
DTEND;VALUE=DATE:20240901
DTSTAMP:20260411T022006
CREATED:20240125T172918Z
LAST-MODIFIED:20240125T172939Z
UID:3919-1724716800-1725148799@scge.mcw.edu
SUMMARY:Genome Engineering: CRISPR Frontiers
DESCRIPTION:The specific goal for this meeting is to foster fruitful and creative interactions between researchers interested in applying these systems to genome engineering and related advances in a wide variety of organisms\, together with scientists studying the basic biology of CRISPR-Cas and related bacterial defense systems. \nCold Spring Harbor\, NY \nhttps://meetings.cshl.edu/meetings.aspx?meet=crispr&year=24
URL:https://scge.mcw.edu/events/genome-engineering-crispr-frontiers-4/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/01/Screenshot-2024-01-25-112826.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240910
DTEND;VALUE=DATE:20240913
DTSTAMP:20260411T022006
CREATED:20240612T154901Z
LAST-MODIFIED:20240612T154901Z
UID:4286-1725926400-1726185599@scge.mcw.edu
SUMMARY:Gene Therapy for Ophthalmic Disorders Summit
DESCRIPTION:Join 100+ industry leaders at the 5th Gene Therapy for Ophthalmic Disorders Summit to uncover cutting-edge gene therapy breakthroughs. Harness the latest developments in vector engineering to target retinal cells more effectively with higher transduction efficiency. Understand the crucial role of endpoint selection to clearly demonstrate product efficacy to the FDA & EMA. Understand the risk-benefit profiles of different ocular administration routes including intravitreal\, subretinal\, and suprachoroidal delivery to choose the best option for your specific indication. Learn from successful clinical trials as well as where trials have fallen short of expectations to take forward crucial lessons learnt on progressing a gene therapy rapidly through the clinic without compromising on safety. \nBoston\, MA
URL:https://scge.mcw.edu/events/gene-therapy-for-ophthalmic-disorders-summit/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-104844.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240910T100000
DTEND;TZID=America/Chicago:20240910T103000
DTSTAMP:20260411T022006
CREATED:20240820T163056Z
LAST-MODIFIED:20240820T163056Z
UID:4442-1725962400-1725964200@scge.mcw.edu
SUMMARY:Webinar: Considerations in leveraging the Universal AAV Standard for dPCR to assess AAV genomes quantity and quality
DESCRIPTION:This webinar will explore the utility of a Universal AAV Standard in assessing the quantity and genomic integrity of AAV vectors. The Universal AAV Standard combines multiple target sites for commonly used promoters\, poly(A) regions and functional CDS. Stacking of these elements in Universal AAV Standard allows it to serve as a single positive control for evaluating the performance of dPCR assays and assessing the quantity\, quality\, and genomic integrity of AAV genomes. \nRegister at https://www.workcast.com/register?cpak=5801990019211892&referrer=tw  \n 
URL:https://scge.mcw.edu/events/webinar-considerations-in-leveraging-the-universal-aav-standard-for-dpcr-to-assess-aav-genomes-quantity-and-quality/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-20-112916.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240919
DTEND;VALUE=DATE:20240921
DTSTAMP:20260411T022006
CREATED:20240808T143712Z
LAST-MODIFIED:20240808T143712Z
UID:4358-1726704000-1726876799@scge.mcw.edu
SUMMARY:HI-POCT 2024
DESCRIPTION:IEEE-EMBS International Conference on Health Innovations in Point of Care Technology (IEEE HI-POCT) is the premier conference in the areas of Health innovations in point-of-care technologies. In its eighth year\, this IEEE EMB Strategic Conference will emphasize funding opportunities and the promise and pitfalls of the journey from idea to patient. The conference will provide a strategic forum in which clinicians\, industry experts\, innovation experts\, researchers\, and students will examine how to define unmet clinical needs and successfully travel along the innovation cycle toward commercialization and patient impact. Clinical\, technological\, regulatory\, and marketing aspects of this learnable process will be stressed. Expert panels will discuss learnings in the development\, translation\, and commercialization of technologies and challenges in bringing medical care innovation to community health. \nTuscon\, AZ \n\nHome \n\n 
URL:https://scge.mcw.edu/events/hi-poct-2024/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-08-093624.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240920T073000
DTEND;TZID=America/Chicago:20240920T173000
DTSTAMP:20260411T022006
CREATED:20240710T134050Z
LAST-MODIFIED:20240710T134155Z
UID:4307-1726817400-1726853400@scge.mcw.edu
SUMMARY:The Safe and Effective Practice of AAV Gene Therapy
DESCRIPTION:Join the Clinical In Vivo Gene Therapy (CIGT) team at Children’s Hospital of Philadelphia for an exciting one-day educational symposium\, as we provide fundamental knowledge on the safe and effective practice of adeno-associated virus (AAV) gene therapy across medical specialties. SCGE researchers Lindsey George\, Beverly Davidson\, and Rebecca Ahrens-Nicklas are scheduled to be speaking at the event. \nFriday September 20\, 2024 || Philadelphia\, PA \nView the registration info here
URL:https://scge.mcw.edu/events/the-safe-and-effective-practice-of-aav-gene-therapy/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/07/Screenshot-2024-07-10-083625.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240920T100000
DTEND;TZID=America/Chicago:20240920T153000
DTSTAMP:20260411T022006
CREATED:20240723T134352Z
LAST-MODIFIED:20240723T134352Z
UID:4333-1726826400-1726846200@scge.mcw.edu
SUMMARY:Meeting 1: Patient and Care Partner Perspectives on Safety Considerations for Approved Gene Therapy Treatments for Rare Diseases
DESCRIPTION:The FDA Center for Biologics Evaluation and Research (CBER) is hosting a public patient listening meeting and opening a docket to better understand patient and care partner perspectives on safety considerations and long-term follow-up for approved gene therapy treatments for rare diseases. \nThe objectives of this listening meeting are to hear from patients and care partners on their perspectives on short-term and long-term risks of approved gene therapy products\, to learn what types of information patients would find helpful in their decision-making when considering gene therapy\, to learn about their considerations and experience with participating in long-term studies after receiving a gene therapy\, and to help inform patient-centered protocols for long-term studies that include gene therapy outcomes.  The meeting will be divided into two sessions. \nRegister for the Zoom meeting here: https://web.cvent.com/event/0b2da86e-f7d1-4288-9d11-2cb9cabe87c5/regProcessStep \nRegistration will close on Thursday\, September 19\, 2024\, at 11:59 pm ET. A recording and other relevant meeting materials will be posted online following the event.
URL:https://scge.mcw.edu/events/meeting-1-patient-and-care-partner-perspectives-on-safety-considerations-for-approved-gene-therapy-treatments-for-rare-diseases/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/07/Screenshot-2024-07-23-084318.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240923
DTEND;VALUE=DATE:20240925
DTSTAMP:20260411T022007
CREATED:20240820T162113Z
LAST-MODIFIED:20240820T162211Z
UID:4435-1727049600-1727222399@scge.mcw.edu
SUMMARY:2024 Policy Summit
DESCRIPTION:The 2024 Policy Summit will include experts on topics such as global regulatory harmonization\, clinical development challenges\, the payment policy landscape\, CGT investment insights\, and more. Join other cell and gene therapy professionals at this 1.5-day event to learn about public policies and regulatory trends impacting the field. \nWashington DC/Hybrid \nRegister at https://www.asgct.org/advocacy/events-and-opportunities/policy-summit/registration \n 
URL:https://scge.mcw.edu/events/2024-policy-summit/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/ASGCT-policy-summit.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240924
DTEND;VALUE=DATE:20240927
DTSTAMP:20260411T022007
CREATED:20240808T145035Z
LAST-MODIFIED:20240808T145035Z
UID:4365-1727136000-1727395199@scge.mcw.edu
SUMMARY:3rd Annual Lipid Nanoparticles Development Summit Europe
DESCRIPTION:The 3rd Lipid Nanoparticles Development Summit Europe is your premier forum to collaborate with a carefully curated community of experts across Discovery\, Characterisation\, Translatability\, Formulation\, Biodistribution\, Manufacturing and much more. These industry leaders are gathering in Berlin this September to bring the greatest challenges in LNP development to the fore\, tackling them head on to ensure 2024 is the year of the LNP. \nBerlin\, Germany \nLearn more at: https://lipid-nanoparticle-development-europe.com/ 
URL:https://scge.mcw.edu/events/3rd-annual-lipid-nanoparticles-development-summit-europe/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-08-095000.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240925
DTEND;VALUE=DATE:20240929
DTSTAMP:20260411T022007
CREATED:20240102T191519Z
LAST-MODIFIED:20240102T192205Z
UID:3427-1727222400-1727567999@scge.mcw.edu
SUMMARY:Week in RARE
DESCRIPTION:Week in RARE\, presented by Global Genes\, features the RARE Health Equity Forum and the RARE Advocacy Summit. \nThe RARE Health Equity Forum convenes stakeholders in the rare disease space to identify ways in which we can better serve marginalized populations within the rare disease community. In its third year\, the event will be focused on the theme of “Equity In Action”. \nThe RARE Advocacy Summit provides the opportunity to forge meaningful connections with others in the rare disease community for future collaboration. Sessions provide attendees with insights about the latest in rare disease innovations\, best practices for advocating on an individual and organizational level\, and actionable strategies they can take home and implement immediately to accelerate change. \nFind more information at: https://www.globalgenes.org/week-in-rare/
URL:https://scge.mcw.edu/events/rare-health-equity-forum/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/01/gg-logo-400x172_globalgenes.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240925
DTEND;VALUE=DATE:20240928
DTSTAMP:20260411T022007
CREATED:20240711T170555Z
LAST-MODIFIED:20240711T170555Z
UID:4318-1727222400-1727481599@scge.mcw.edu
SUMMARY:RESI Boston 2024
DESCRIPTION:The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain\, connecting start-ups with 10 categories of global investors across the silos of drugs\, devices\, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups\, those seeking grants\, seed and angel capital\, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare. \n9/25 – Boston \n9/26 and 9/27 – Virtual \nhttps://resiconference.com/ 
URL:https://scge.mcw.edu/events/resi-boston-2024/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/07/Screenshot-2024-07-11-120532.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241014
DTEND;VALUE=DATE:20241017
DTSTAMP:20260411T022007
CREATED:20240612T155954Z
LAST-MODIFIED:20240612T155954Z
UID:4294-1728864000-1729123199@scge.mcw.edu
SUMMARY:7th International Conference on CRISPR Technologies
DESCRIPTION:CRISPR 2024 is an exclusive conference that unites leaders from industry\, government agencies\, and academia to discuss the latest advancements in genome editing technologies. The program brings together experts from diverse fields to discuss how to safely and effectively translate these cutting-edge technologies to patients\, while remaining mindful of the ethical implications. \nSan Diego\, CA
URL:https://scge.mcw.edu/events/7th-international-conference-on-crispr-technologies/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-105925.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241016
DTEND;VALUE=DATE:20241018
DTSTAMP:20260411T022007
CREATED:20240612T155628Z
LAST-MODIFIED:20240612T155628Z
UID:4292-1729036800-1729209599@scge.mcw.edu
SUMMARY:Advancing Gene and Cell Therapies for Cancer
DESCRIPTION:During this conference\, experts in the field will share their insights on targeting cancer-specific antigens\, highlight rational combinations to further enhance the function of CAR engineered cells\, describe ground-breaking efforts to engineer CAR engineered cells directly in vivo\, and illuminate the biology and risks of viral vector integration. \nPhiladelphia\, PA and Virtual
URL:https://scge.mcw.edu/events/advancing-gene-and-cell-therapies-for-cancer/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-103632.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241016
DTEND;VALUE=DATE:20241018
DTSTAMP:20260411T022007
CREATED:20241014T135948Z
LAST-MODIFIED:20241014T140258Z
UID:4571-1729036800-1729209599@scge.mcw.edu
SUMMARY:2024 STAT Summit
DESCRIPTION:By gathering real operators from the trenches who have not previously spoken out\, not just talking heads\, this event covers some of the biggest challenges faced by those who want to move advances out of the lab and into the world. They will discuss everything from drug development and technology invention to dealing with regulators\, courting investors\, and pricing and selling products. \nHear from SCGE Phase 2 researchers Sonia Vallabh and Allyson Berent at this event! Sonia presents at 12:05pm ET on 10/16\, and Allyson presents at 3:45pm ET on 10/17. \nFind more info at: https://www.statnews.com/2024/summit/2024-stat-summit-2/ \nBoston\, MA or Virtual
URL:https://scge.mcw.edu/events/2024-stat-summit/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/10/Screenshot-2024-10-14-085854.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20241016T090000
DTEND;TZID=America/Chicago:20241016T133000
DTSTAMP:20260411T022007
CREATED:20241010T143855Z
LAST-MODIFIED:20241010T144012Z
UID:4567-1729069200-1729085400@scge.mcw.edu
SUMMARY:Advancing Rare Disease Therapies Through an FDA Rare Disease Innovation Hub
DESCRIPTION:The Reagan-Udall Foundation for the FDA\, in collaboration with FDA’s Rare Disease Innovation Hub\, will host a public meeting on October 16\, 2024. The meeting will bring together rare disease patient advocates\, academic researchers\, regulated industry\, and other key stakeholders to discuss how the recently announced Rare Disease Innovation Hub can best engage with members of the rare disease community and prioritize its work. \nHybrid Public Meeting: In-Person and Virtual \nOctober 16\, 2024 | 10am-2:30pm ET \nRegister at: https://reaganudall.org/news-and-events/events/advancing-rare-disease-therapies-through-an-fda-rare-disease-innovation-hub
URL:https://scge.mcw.edu/events/advancing-rare-disease-therapies-through-an-fda-rare-disease-innovation-hub/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/10/Screenshot-2024-10-10-093752.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241022
DTEND;VALUE=DATE:20241026
DTSTAMP:20260411T022007
CREATED:20240612T155327Z
LAST-MODIFIED:20240612T155327Z
UID:4289-1729555200-1729900799@scge.mcw.edu
SUMMARY:World Orphan Drug Congress Europe
DESCRIPTION:The World Orphan Drug Congress is the largest and most established orphan drugs & rare diseases meeting of its kind across the globe. \nBarcelona\, Spain
URL:https://scge.mcw.edu/events/world-orphan-drug-congress-europe/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-105300.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241030
DTEND;VALUE=DATE:20241102
DTSTAMP:20260411T022007
CREATED:20240808T144734Z
LAST-MODIFIED:20240808T144734Z
UID:4362-1730246400-1730505599@scge.mcw.edu
SUMMARY:6th Annual Gene Therapy Analytical Development & CMC Summit
DESCRIPTION:The 6th Gene Therapy Analytical Development & CMC Summit will unite 250+ analytical development\, CMC\, QC\, and process development experts to showcase innovative analytical and process development methods\, assess their readiness\, and ultimately guarantee safety\, quality\, efficacy\, and consistency of gene therapies to regulators. \n\nBoston\, MA \nLearn more at https://www.genetherapy-analytical-cmc.com/
URL:https://scge.mcw.edu/events/6th-annual-gene-therapy-analytical-development-cmc-summit/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-08-094701.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241119
DTEND;VALUE=DATE:20241121
DTSTAMP:20260411T022007
CREATED:20240820T162523Z
LAST-MODIFIED:20240820T162523Z
UID:4439-1731974400-1732147199@scge.mcw.edu
SUMMARY:Breakthroughs in Muscular Dystrophy
DESCRIPTION:Join ASGCT and the Muscular Dystrophy Association in downtown Chicago for an unparalleled opportunity to delve into the latest advancements in research on gene and cell therapies for muscular dystrophy. This 1.5-day event will bring together leading researchers and clinicians from the neuromuscular disease community to explore cutting-edge gene and cell therapies and technologies for muscular dystrophy. \nChicago\, IL \nhttps://www.asgct.org/events/breakthroughs-in-muscular-dystrophy/registration
URL:https://scge.mcw.edu/events/breakthroughs-in-muscular-dystrophy/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-20-112456.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20241120T080000
DTEND;TZID=America/Chicago:20241120T150000
DTSTAMP:20260411T022007
CREATED:20241029T213601Z
LAST-MODIFIED:20241029T213601Z
UID:4634-1732089600-1732114800@scge.mcw.edu
SUMMARY:FDA Scientific Exchange 2024: Advancing Gene Editing Platforms for Rare Diseases
DESCRIPTION:On November 20th\, ISCT\, ARM\, and Danaher will convene key stakeholders to explore how to advance gene editing platforms. This Scientific Exchange with the FDA seeks to make progress on therapeutic development for rare conditions that are scientifically feasible but commercially non-viable. The Exchange will review case studies from academics and industry developers focused on gene editing\, with the objective of defining repeatable platforms that streamline development and regulatory requirements across multiple therapies for rare populations. Successful platforms hold promise to deliver faster and broader patient access to novel gene therapies while maintaining favorable risk-benefit balance and appropriate regulatory rigor. The attached background materials provide additional context. \nThe event will be live-streamed. \nRegister at https://www.isctglobal.org/event/fda-scientific-exchange-2024
URL:https://scge.mcw.edu/events/fda-scientific-exchange-2024-advancing-gene-editing-platforms-for-rare-diseases/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/10/Screenshot-2024-10-29-163510.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20241122T120000
DTEND;TZID=America/Chicago:20241122T124500
DTSTAMP:20260411T022007
CREATED:20241022T150033Z
LAST-MODIFIED:20241022T150033Z
UID:4597-1732276800-1732279500@scge.mcw.edu
SUMMARY:Real-World Evidence Webinar Series: Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice
DESCRIPTION:The Reagan-Udall Foundation for the FDA\, in collaboration with the Food and Drug Administration (FDA)\, is hosting a public webinar as part of a series of webinars for FDA-issued guidance related to real-world evidence (RWE). This latest session in the webinar series will discuss the draft guidance: Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice. \nThe guidance document addresses randomized controlled trials (RCTs) that have been integrated within routine clinical practice. Such RCTs have streamlined protocols that focus on collection of essential data and are often referred to as point-of-care or large\, simple trials. The guidance document discusses how leveraging established health care institutions can help reduce startup time and support trial enrollment. Involving local health care providers also offers convenience and accessibility to diverse patient populations who may not otherwise have the opportunity to participate. \nRegister at https://reaganudall.org/news-and-events/events/real-world-evidence-webinar-series-integrating-randomized-controlled-trials
URL:https://scge.mcw.edu/events/real-world-evidence-webinar-series-integrating-randomized-controlled-trials-for-drug-and-biological-products-into-routine-clinical-practice/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/10/Screenshot-2024-10-22-095942.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20250122T080000
DTEND;TZID=America/Chicago:20250123T120000
DTSTAMP:20260411T022007
CREATED:20241111T160743Z
LAST-MODIFIED:20241111T160743Z
UID:4654-1737532800-1737633600@scge.mcw.edu
SUMMARY:Class Considerations on Immunogenicity for AAV Gene Therapy Products: Assessing Current Practice and New Data
DESCRIPTION:ASGCT and FDA will host a virtual scientific workshop over two half days. This free\, public event will explore key immunology-related topics that have implications across the class of AAV gene therapies\, including immune responses\, antibody testing\, and redosing strategies. The workshop will provide valuable insights for professionals in both academia and industry as it addresses pressing challenges in AAV gene therapies and new approaches. \nRegister at: https://www.asgct.org/asgct-events/january-2025/class-considerations-on-immunogenicity-for-aav-gen \n 
URL:https://scge.mcw.edu/events/class-considerations-on-immunogenicity-for-aav-gene-therapy-products-assessing-current-practice-and-new-data/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/11/Screenshot-2024-11-11-100705.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250128
DTEND;VALUE=DATE:20250131
DTSTAMP:20260411T022007
CREATED:20240612T152939Z
LAST-MODIFIED:20240612T152939Z
UID:4271-1738022400-1738281599@scge.mcw.edu
SUMMARY:WCBP Symposium
DESCRIPTION:Stay tuned for more details.\n\nThe Mayflower Hotel in Washington D.C.\, United States.\n\nhttps://www.casss.org/meetings-and-events/event/2025/01/28/default-calendar/wcbp-2025
URL:https://scge.mcw.edu/events/wcbp-symposium/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-102903.png
END:VEVENT
END:VCALENDAR